Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases

Release Time:2024-09-03  Hits:

Indexed by: Journal Papers

Document Code: 371945

Date of Publication: 2023-08-25

Journal: CHEMICO-BIOLOGICAL INTERACTIONS

Volume: 381

ISSN: 0009-2797

Key Words: GLUCURONIDATION; IC50; PHARMACOGENOMICS; PHARMACOKINETICS; PREDICTION

Prev One:Avapritinib Carries the Risk of Drug Interaction via Inhibition of UDP-Glucuronyltransferase (UGT) 1A1

Next One:In vitro inhibitory effects of selumetinib on activity of human UDP-glucuronosyltransferases and prediction of in vivo drug-drug interactions